D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 140 Citations 80,317 933 World Ranking 926 National Ranking 101

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Breast cancer, Internal medicine, Cancer, Oncology and Genetics. D. Gareth Evans combines subjects such as Cancer research, Genetic predisposition, Gynecology and Single-nucleotide polymorphism, Genotype with his study of Breast cancer. His work is dedicated to discovering how Cancer, Genetic counseling are connected with Family history and other disciplines.

His Oncology study also includes fields such as

  • Prospective cohort study, which have a strong connection to Obstetrics,
  • Gene mutation which intersects with area such as Estrogen receptor. D. Gareth Evans works mostly in the field of Risk factor, limiting it down to concerns involving Relative risk and, occasionally, Neurofibromatosis. His Ovarian cancer research includes elements of Serous fluid and Cohort study.

His most cited work include:

  • Genome-wide association study identifies novel breast cancer susceptibility loci (2045 citations)
  • Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality (965 citations)
  • Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations (902 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Cancer and Genetics. His Breast cancer study integrates concerns from other disciplines, such as Prospective cohort study, Gynecology, Family history and Family medicine. His biological study deals with issues like Germline mutation, which deal with fields such as Germline.

His work in Oncology addresses issues such as Cohort, which are connected to fields such as Cohort study. His Cancer research includes themes of Cancer research and Risk factor. Mutation, Allele, Single-nucleotide polymorphism, Genotype and Genome-wide association study are among the areas of Genetics where D. Gareth Evans concentrates his study.

He most often published in these fields:

  • Breast cancer (56.96%)
  • Internal medicine (43.77%)
  • Oncology (35.36%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (43.77%)
  • Breast cancer (56.96%)
  • Oncology (35.36%)

In recent papers he was focusing on the following fields of study:

D. Gareth Evans mainly focuses on Internal medicine, Breast cancer, Oncology, Cancer and Family medicine. In his study, which falls under the umbrella issue of Internal medicine, Medical genetics, Li–Fraumeni syndrome, Bioinformatics and Germline mutation is strongly linked to Germline. His studies deal with areas such as Proportional hazards model, Cohort study and Obstetrics as well as Breast cancer.

His studies examine the connections between Oncology and genetics, as well as such issues in PALB2, with regards to CHEK2. His Cancer study frequently links to other fields, such as Gene. D. Gareth Evans has researched Family medicine in several fields, including Underserved Population and Breast screening.

Between 2019 and 2021, his most popular works were:

  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (96 citations)
  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (96 citations)
  • Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families (68 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

D. Gareth Evans focuses on Internal medicine, Breast cancer, Oncology, Lynch syndrome and Family medicine. D. Gareth Evans frequently studies issues relating to Germline and Internal medicine. The various areas that D. Gareth Evans examines in his Breast cancer study include Odds ratio, Cohort study and Hazard ratio.

His Oncology research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism, Genetic association, Cohort and PALB2. His Lynch syndrome research focuses on Endometrial cancer and how it connects with MLH1, MSH2, Colorectal cancer, MSH6 and Genetic counseling. His research integrates issues of Young adult, Phenotype, Malignancy and Genomics in his study of Cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies

A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch.
American Journal of Human Genetics (2003)

4309 Citations

Genome-wide association study identifies novel breast cancer susceptibility loci

Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Nature (2007)

2713 Citations

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
JAMA (2017)

1731 Citations

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans.
JAMA (2010)

1437 Citations

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Timothy R. Rebbeck;Tara Friebel;Henry T. Lynch;Susan L. Neuhausen.
Journal of Clinical Oncology (2004)

1370 Citations

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski.
Nature Genetics (2002)

1313 Citations

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

M O Leach;C R M Boggis;A K Dixon;D F Easton.
The Lancet (2005)

1253 Citations

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

D G R Evans;M E Baser;J McGaughran;S Sharif.
Journal of Medical Genetics (2002)

1241 Citations

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

Nazneen Rahman;Sheila Seal;Deborah Thompson;Patrick Kelly.
Nature Genetics (2007)

1075 Citations

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

John Burn;Anne Marie Gerdes;Finlay MacRae;Jukka Pekka Mecklin.
The Lancet (2011)

1042 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing D. Gareth Evans

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 305

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 264

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 243

Douglas F. Easton

Douglas F. Easton

University of Trieste

Publications: 239

Steven A. Narod

Steven A. Narod

University of Toronto

Publications: 224

Melissa C. Southey

Melissa C. Southey

Monash University

Publications: 218

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 194

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 193

Ian Tomlinson

Ian Tomlinson

University of Edinburgh

Publications: 183

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 179

Jan Lubinski

Jan Lubinski

Pomeranian Medical University

Publications: 173

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 165

Esther M. John

Esther M. John

Stanford University

Publications: 158

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 158

Dominique Stoppa-Lyonnet

Dominique Stoppa-Lyonnet

Institute Curie

Publications: 154

Hiltrud Brauch

Hiltrud Brauch

German Cancer Research Center

Publications: 151

Trending Scientists

Michael Mateas

Michael Mateas

University of California, Santa Cruz

Nadathur Satish

Nadathur Satish

Facebook (United States)

Tao Yu

Tao Yu

South China University of Technology

Hiroyuki Ohshima

Hiroyuki Ohshima

Tokyo University of Science

Jianjun Tian

Jianjun Tian

University of Science and Technology Beijing

Hyun M. Jang

Hyun M. Jang

Seoul National University

Sándor Damjanovich

Sándor Damjanovich

University of Debrecen

Nadir M. Maraldi

Nadir M. Maraldi

National Academies of Sciences, Engineering, and Medicine

Chris M. Grant

Chris M. Grant

University of Manchester

Andrew S. Pullin

Andrew S. Pullin

Bangor University

Neil H. Kenyon

Neil H. Kenyon

University of Southampton

W. Stern

W. Stern

Geophysical Fluid Dynamics Laboratory

Elemer Szabadi

Elemer Szabadi

University of Nottingham

Gregory M. Brown

Gregory M. Brown

University of Toronto

Gary Klein

Gary Klein

MacroCognition LLC

Anne Rasmussen

Anne Rasmussen

Leiden University

Something went wrong. Please try again later.